ACYCLOVIR AND HYDROCORTISONE

ACYCLOVIR AND HYDROCORTISONE was reported 40 times

ACYCLOVIR AND HYDROCORTISONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERNATIONAL NORMALISED RATIO 1 0.0062
1 PHARYNGEAL PARAESTHESIA 9 0.0057
2 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
3 SEXUALLY TRANSMITTED DISEASE 1 0.0023
4 ALLERGY TO ARTHROPOD STING 1 0.0022
5 INTRAOCULAR PRESSURE DECREASED 1 0.0019
6 IMMUNISATION REACTION 1 0.0014
7 THROMBOTIC STROKE 1 0.0014
8 PERTUSSIS 1 0.0010
9 DEAFNESS BILATERAL 1 0.0006
10 UTERINE POLYP 1 0.0006
11 MYOPIA 1 0.0004
12 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
13 DEVICE INFUSION ISSUE 1 0.0004
14 FREEZING PHENOMENON 1 0.0003
15 HYPERURICAEMIA 1 0.0002
16 AORTIC VALVE INCOMPETENCE 1 0.0002
17 PRODUCT DISPENSING ISSUE 1 0.0002
18 CHAPPED LIPS 1 0.0002
19 INCORRECT DOSAGE ADMINISTERED 1 0.0002
20 APPLICATION SITE SWELLING 1 0.0002
21 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
22 MACULAR OEDEMA 1 0.0002
23 INFLAMMATION 9 0.0002
24 EXERCISE TOLERANCE DECREASED 1 0.0002
25 INFUSION SITE SWELLING 1 0.0002
26 HERPES SIMPLEX 1 0.0002
27 UTERINE LEIOMYOMA 1 0.0001
28 HIDRADENITIS 1 0.0001
29 RETINAL DETACHMENT 1 0.0001
30 NERVE COMPRESSION 1 0.0001
31 BLADDER DISORDER 1 0.0001
32 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
33 APPLICATION SITE PAIN 2 0.0001
34 SCAB 1 0.0001
35 PHARYNGITIS 1 0.0001
36 INFUSION SITE PAIN 1 0.0001
37 OEDEMA PERIPHERAL 9 0.0001
38 CORONARY ARTERY OCCLUSION 1 0.0001
39 ORAL DISCOMFORT 1 0.0001
40 DIALYSIS 1 0.0001
41 SKIN HAEMORRHAGE 1 0.0001
42 HERPES ZOSTER 3 0.0001
43 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
44 PRODUCT PRESCRIBING ISSUE 1 0.0000
45 PRODUCT AVAILABILITY ISSUE 1 0.0000
46 APPLICATION SITE ERYTHEMA 1 0.0000
47 FREQUENT BOWEL MOVEMENTS 1 0.0000
48 ARTHROPATHY 2 0.0000
49 EXPIRED PRODUCT ADMINISTERED 1 0.0000
50 SKIN DISORDER 1 0.0000
51 RASH MACULAR 1 0.0000
52 HYPERKALAEMIA 1 0.0000
53 PLASMA CELL MYELOMA 1 0.0000
54 RENAL DISORDER 1 0.0000
55 LUNG DISORDER 1 0.0000
56 ECZEMA 1 0.0000
57 HAEMATOCHEZIA 1 0.0000
58 PAIN 11 0.0000
59 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
60 PRODUCT DOSE OMISSION 1 0.0000
61 BLOOD PRESSURE DECREASED 1 0.0000
62 THERAPY INTERRUPTED 1 0.0000
63 BRONCHITIS 1 0.0000
64 PARAESTHESIA 2 0.0000
65 INJECTION SITE BRUISING 1 0.0000
66 MYOCARDIAL INFARCTION 2 0.0000
67 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
68 GASTROINTESTINAL DISORDER 1 0.0000
69 SWELLING 1 0.0000
70 ATRIAL FIBRILLATION 1 0.0000
71 PAIN IN EXTREMITY 3 0.0000
72 SYNCOPE 1 0.0000
73 ILLNESS 1 0.0000
74 DEHYDRATION 1 0.0000
75 NEUTROPENIA 1 0.0000
76 VISION BLURRED 1 0.0000
77 INFECTION 1 0.0000
78 PERIPHERAL SWELLING 1 0.0000
79 COVID-19 1 0.0000
80 NO ADVERSE EVENT 1 0.0000
81 HYPERSENSITIVITY 1 0.0000
82 PRODUCT USE ISSUE 1 0.0000
83 GAIT DISTURBANCE 1 0.0000
84 ALOPECIA 1 0.0000
85 HYPOTENSION 1 0.0000
86 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
87 HYPERTENSION 1 0.0000
88 RASH 2 0.0000
89 CONSTIPATION 1 0.0000
90 OFF LABEL USE 4 0.0000
91 MALAISE 2 0.0000
92 WEIGHT INCREASED 1 0.0000
93 INCORRECT DOSE ADMINISTERED 1 0.0000
94 DECREASED APPETITE 1 0.0000
95 ABDOMINAL PAIN 1 0.0000
96 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
97 WEIGHT DECREASED 1 0.0000
98 CONDITION AGGRAVATED 1 0.0000
99 PYREXIA 1 0.0000
100 ARTHRALGIA 1 0.0000
101 DRUG INEFFECTIVE 3 0.0000
102 VOMITING 1 0.0000
103 DIZZINESS 1 0.0000
104 HEADACHE 1 0.0000
105 DIARRHOEA 1 0.0000
106 FATIGUE 1 0.0000